Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|41|5964-5976

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.41, 2015-12, pp. : 5964-5976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Crosstalk of RAS with the TGF-&bgr; Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 849-857

Bentham Science Publishers

Access to resources Recommend Favorite

GFAP Promoter-Driven RNA Interference on TGF-β1 to Treat Liver Fibrosis

By Yang Ningning   Mahato Ram  

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 752-761

Springer Publishing Company

Access to resources Recommend Favorite

Evidence for cross-talk between stanniocalcins

By Paciga Mark   James Kathi   Gillespie J Ryan J   Wagner Graham F  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 11, 2005-11 ,pp. : 953-956

NRC Research Press

Access to resources Recommend Favorite

Angiotensin-TGF-&bgr;1 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages

By  

Current Pharmaceutical Design, Vol. 13, Iss. 12, 2007-04 ,pp. : 1247-1256

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Translocation During the Cross-Talk Between Cellular Stress, Cell Cycle and Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 13, Iss. 11, 2006-05 ,pp. : 1317-1320

Bentham Science Publishers

Access to resources Recommend Favorite